Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

McKinsey
Medtronic
Dow
Colorcon
Baxter
Moodys

Last Updated: December 16, 2019

DrugPatentWatch Database Preview

Gonadotropin, chorionic - Generic Drug Details

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

What are the generic drug sources for gonadotropin, chorionic and what is the scope of patent protection?

Gonadotropin, chorionic is the generic ingredient in four branded drugs marketed by Ferring, Bel Mar, Fresenius Kabi Usa, Bristol Myers Squibb, and Organon Usa Inc, and is included in six NDAs. Additional information is available in the individual branded drug profile pages.

Three suppliers are listed for this compound.

Summary for gonadotropin, chorionic
Recent Clinical Trials for gonadotropin, chorionic

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Moustafa Mohammed AboueleaEarly Phase 1
Assistance Publique - Hôpitaux de ParisPhase 2
Sohag UniversityPhase 4

See all gonadotropin, chorionic clinical trials

US Patents and Regulatory Information for gonadotropin, chorionic

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Ferring CHORIONIC GONADOTROPIN gonadotropin, chorionic INJECTABLE;INJECTION 017016-006 Approved Prior to Jan 1, 1982 RX Yes Yes   Start Trial   Start Trial   Start Trial
Ferring CHORIONIC GONADOTROPIN gonadotropin, chorionic INJECTABLE;INJECTION 017016-007 Approved Prior to Jan 1, 1982 AP RX Yes Yes   Start Trial   Start Trial   Start Trial
Ferring CHORIONIC GONADOTROPIN gonadotropin, chorionic INJECTABLE;INJECTION 017016-011 Feb 16, 1990 DISCN No No   Start Trial   Start Trial   Start Trial
Ferring CHORIONIC GONADOTROPIN gonadotropin, chorionic INJECTABLE;INJECTION 017016-009 Dec 27, 1984 DISCN No No   Start Trial   Start Trial   Start Trial
Ferring CHORIONIC GONADOTROPIN gonadotropin, chorionic INJECTABLE;INJECTION 017016-010 Feb 15, 1985 DISCN No No   Start Trial   Start Trial   Start Trial
Bel Mar CHORIONIC GONADOTROPIN gonadotropin, chorionic INJECTABLE;INJECTION 017054-002 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Baxter
Colorcon
Moodys
McKinsey
AstraZeneca
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.